With extensive expertise in sterile fill/finish operations and a robust track record in scaling production, Recipharm can offer the agility and capacity that pharmaceutical companies require to meet market needs efficiently
Pharmacy trips add more hassle
For people with recent-onset type 2 diabetes, bariatric surgery may be considered at a lower BMI threshold of 30-34.9 kg/m
The efficacy advantages ripple through to mortality and morbidity, conferring still more clinical benefit
[PMID 38958939, PMID 39976940, PMID 42060879] CONTRAINDICATIONS A personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) A prior serious hypersensitivity reaction to semaglutide or to any of the excipients in Wegovy PRECAUTIONS Kidney disease No dose adjustment is necessary for any degree of renal impairment Liver disease No dose adjustment is necessary for any degree of hepatic impairment Stomach disorders Wegovy slows gastric emptying and is not recommended in patients with significant stomach disorders, including diabetic gastroparesis General anesthesia or deep sedation GLP-1 therapies, like Wegovy, slow gastric emptying, possibly increasing the risk of residual gastric contents and pulmonary aspiration in patients receiving anesthesia or deep sedation for procedures